Vicore Pharma Posts Q3 Loss of SEK 0.44 Per Share as Revenue Falls 25%

Net loss widened to SEK 124.3 million, and cash, cash equivalents and short-term investments totaled SEK 772 million at Sept. 30, 2026.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.